{"disease":{"id":"ctdna","name":"ctdna"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07176962","title":"A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Yingbin Liu, MD, PhD, FACS","has_results":false},{"nct_id":"NCT07283575","title":"Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)","phase":"","overall_status":"RECRUITING","enrollment_count":497,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06970912","title":"ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":393,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04084249","title":"ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":359,"lead_sponsor_name":"Claus Lindbjerg Andersen","has_results":false},{"nct_id":"NCT07254156","title":"A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":229,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05027347","title":"Detection of Plasma Circulating Tumor DNA in Gastric Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT07366112","title":"CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":158,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07394218","title":"ctDNA-guided Treatment Decision-making","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":122,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05635630","title":"Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05029869","title":"Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT06707974","title":"Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07371247","title":"Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy","phase":"EARLY_PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":65,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT07121335","title":"SMC Radiation Oncology SABR Cohort for Oligometastasis","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06649838","title":"Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05441566","title":"Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":60,"lead_sponsor_name":"Shenzhen People's Hospital","has_results":false},{"nct_id":"NCT03805256","title":"Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Second Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06199232","title":"Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":47,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT06287749","title":"French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)","phase":"","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07507916","title":"Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05513144","title":"Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"chenwu","has_results":false},{"nct_id":"NCT06792786","title":"A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"The Central Hospital of Lishui City","has_results":false},{"nct_id":"NCT07478705","title":"Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT06287723","title":"French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07292207","title":"Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Nagoya City University","has_results":false},{"nct_id":"NCT04741633","title":"Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07136077","title":"A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07475923","title":"Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}